(Q35229595)

7 August 2017

1 reference

title

The quinolones. An overview of their pharmacology (English)

1 reference

7 August 2017

0 references

A. Fitton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319865

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1319865

13 September 2022

publication date

1 January 1992

1 reference

Clinical Pharmacokinetics

7 August 2017

published in

1 reference

7 August 2017

volume

22 Suppl 1

1 reference

7 August 2017

page(s)

1-11

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199200221-00003

7 August 2017

exact match

0 references

cites work

Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections

1 reference

12 December 2020

1 reference

12 December 2020

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

1 reference

12 December 2020

Treatment of nongonococcal urethritis with ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of Temafloxacin in Patients with Liver Impairment†

1 reference

12 December 2020

Tissue penetration of the new quinolones in humans

1 reference

12 December 2020

Effect of Cimetidine on the Pharmacokinetics of Temafloxacin

1 reference

12 December 2020

A review of the antimicrobial activity of the fluoroquinolones.

1 reference

12 December 2020

Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women

1 reference

12 December 2020

Ciprofloxacin therapy in cystic fibrosis

1 reference

12 December 2020

Clinical role of the quinolones today and in the future

1 reference

12 December 2020

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

1 reference

12 December 2020

Drug-drug interactions affecting fluoroquinolones

1 reference

12 December 2020

Central nervous system toxicity of quinolones: human and animal findings

1 reference

12 December 2020

Pharmacokinetics of temafloxacin in humans after single oral doses

1 reference

12 December 2020

Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains

1 reference

12 December 2020

Quinolone antimicrobial agents: adverse effects and bacterial resistance

1 reference

12 December 2020

Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

1 reference

12 December 2020

Pharmacokinetics of quinolones in renal insufficiency

1 reference

12 December 2020

Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Drug interactions with quinolones.

1 reference

12 December 2020

Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel

1 reference

12 December 2020

Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Effects of 2 Quinolone Antibacterials, Temafloxacin and Enoxacin, on Theophylline Pharmacokinetics†

1 reference

12 December 2020

Short-term self-treatment of travellers' diarrhoea with norfloxacin: a placebo-controlled study.

1 reference

12 December 2020

Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects

1 reference

12 December 2020

Safety profile of the quinolones

1 reference

12 December 2020

Specific toxicologic aspects of the quinolones.

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis

1 reference

12 December 2020

Drug interactions with quinolones

1 reference

12 December 2020

Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women

1 reference

12 December 2020

Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group

1 reference

12 December 2020

Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis

1 reference

12 December 2020

Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis

1 reference

12 December 2020

Penetration of Temafloxacin into Body Tissues and Fluids

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antibacterial 4-quinolones

1 reference

12 December 2020

Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection

1 reference

12 December 2020

Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Pharmacokinetics of fluorinated 4-quinolones in the aged

1 reference

12 December 2020

Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.

1 reference

12 December 2020

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

12 December 2020

Adverse effects of the fluoroquinolones.

1 reference

12 December 2020

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial

1 reference

12 December 2020

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

1 reference

12 December 2020

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea

1 reference

12 December 2020

Comparative studies of fluoroquinolones in the treatment of urinary tract infections

1 reference

12 December 2020

Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women

1 reference

12 December 2020

Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.

1 reference

12 December 2020

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.

1 reference

12 December 2020

Effect of Antacid Medication on the Pharmacokinetics of Temafloxacin

1 reference

12 December 2020

Ofloxacin penetration into cerebrospinal fluid

1 reference

12 December 2020

10.2165/00003088-199200221-00003

Identifiers

DOI

0 references

Dimensions Publication ID

1019019891

0 references

1 reference